Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains.

Beran V, Chmelar D, Vobejdova J, Konigova A, Nemec J, Tvrdik J.

Folia Microbiol (Praha). 2014 May;59(3):209-15. doi: 10.1007/s12223-013-0283-1.

PMID:
24114414
2.

[Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].

Poilane I, Fantinato C, Cruaud P, Collignon A.

Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):412-6. doi: 10.1016/j.patbio.2008.07.009. French.

PMID:
18842360
3.

Characterization and antimicrobial susceptibility of Clostridium difficile strains isolated from adult patients with diarrhoea hospitalized in two university hospitals in Poland, 2004-2006.

Pituch H, Obuch-Woszczatyński P, Wultańska D, Nurzyńska G, Harmanus C, Banaszkiewicz A, Radzikowski A, Łuczak M, van Belkum A, Kuijper E.

J Med Microbiol. 2011 Aug;60(Pt 8):1200-5. doi: 10.1099/jmm.0.029801-0.

PMID:
21415206
4.

Shedding of Clostridium difficile PCR ribotype 078 by zoo animals, and report of an unstable metronidazole-resistant isolate from a zebra foal (Equus quagga burchellii).

Álvarez-Pérez S, Blanco JL, Martínez-Nevado E, Peláez T, Harmanus C, Kuijper E, García ME.

Vet Microbiol. 2014 Mar 14;169(3-4):218-22. doi: 10.1016/j.vetmic.2013.12.018.

PMID:
24467928
5.

Molecular characterization of toxigenic Clostridium difficile in a northern Italian hospital.

De Rosa FG, Cavallerio P, Corcione S, Parlato C, Fossati L, Serra R, Di Perri G, Cavallo R.

Curr Microbiol. 2015 Feb;70(2):154-5. doi: 10.1007/s00284-014-0690-9.

PMID:
25245958
6.

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.

Snydman DR, McDermott LA, Jacobus NV, Thorpe C, Stone S, Jenkins SG, Goldstein EJ, Patel R, Forbes BA, Mirrett S, Johnson S, Gerding DN.

Antimicrob Agents Chemother. 2015 Oct;59(10):6437-43. doi: 10.1128/AAC.00845-15.

7.

Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.

Terhes G, Urbán E, Sóki J, Szikra L, Konkoly-Thege M, Vollain M, Nagy E.

Anaerobe. 2009 Dec;15(6):237-40. doi: 10.1016/j.anaerobe.2009.01.010.

PMID:
19682411
8.

Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.

López-Ureña D, Quesada-Gómez C, Montoya-Ramírez M, del Mar Gamboa-Coronado M, Somogyi T, Rodríguez C, Rodríguez-Cavallini E.

Emerg Microbes Infect. 2016 May 11;5:e42. doi: 10.1038/emi.2016.38.

9.

Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.

Citron DM, Babakhani F, Goldstein EJ, Nagaro K, Sambol S, Sears P, Shue YK, Gerding DN.

Anaerobe. 2009 Dec;15(6):234-6. doi: 10.1016/j.anaerobe.2009.09.005.

PMID:
19755166
10.

Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.

Huang H, Wu S, Wang M, Zhang Y, Fang H, Palmgren AC, Weintraub A, Nord CE.

Int J Antimicrob Agents. 2009 Apr;33(4):339-42. doi: 10.1016/j.ijantimicag.2008.09.022.

PMID:
19097757
11.

Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland.

Mutlu E, Wroe AJ, Sanchez-Hurtado K, Brazier JS, Poxton IR.

J Med Microbiol. 2007 Jul;56(Pt 7):921-9.

PMID:
17577057
12.

Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility.

Båverud V, Gustafsson A, Franklin A, Aspán A, Gunnarsson A.

Equine Vet J. 2003 Jul;35(5):465-71. Erratum in: Equine Vet J. 2003 Nov;35(7):706.

PMID:
12875324
13.

[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].

Deniz U, Ulger N, Aksu B, Karavuş M, Söyletir G.

Mikrobiyol Bul. 2011 Jan;45(1):1-10. Turkish.

PMID:
21341153
14.

Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.

Zheng L, Citron DM, Genheimer CW, Sigmon SF, Carman RJ, Lyerly DM, Goldstein EJ.

Anaerobe. 2007 Jun-Aug;13(3-4):114-20.

PMID:
17531516
15.

Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.

Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L.

Infect Control Hosp Epidemiol. 2007 Aug;28(8):932-40.

PMID:
17620240
16.

Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil.

Balassiano IT, Miranda KR, Boente RF, Pauer H, Oliveira IC, Santos-Filho J, Amorim EL, Caniné GA, Souza CF, Gomes MZ, Ferreira EO, Brazier JS, Domingues RM.

Anaerobe. 2009 Jun;15(3):61-4. doi: 10.1016/j.anaerobe.2008.12.007.

PMID:
19154793
17.

Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain.

Kuijper EJ, de Weerdt J, Kato H, Kato N, van Dam AP, van der Vorm ER, Weel J, van Rheenen C, Dankert J.

Eur J Clin Microbiol Infect Dis. 2001 Aug;20(8):528-34.

PMID:
11681431
18.

Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan.

Kuwata Y, Tanimoto S, Sawabe E, Shima M, Takahashi Y, Ushizawa H, Fujie T, Koike R, Tojo N, Kubota T, Saito R.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):763-72. doi: 10.1007/s10096-014-2290-9.

PMID:
25471195
19.
20.

The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.

Sadeghifard N, Salari MH, Ghassemi MR, Eshraghi S, Amin Harati F.

Acta Med Iran. 2010 Sep-Oct;48(5):320-5.

Supplemental Content

Support Center